Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum add-on peginterferon plus nucleotide analogue study in women with chronic hepatitis B
ChiCTR1900024023Phase 4Recruiting
- Sponsor
- The Second Hospital of Nanjing
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) (2 arms), sponsored by The Second Hospital of Nanjing. Primary endpoint: HBsAg negative rate. Started Jul 2019; status: recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1900024023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024023.